基本信息
浏览量:4
职业迁徙
个人简介
The research in the Watts laboratory is designed to use a multi-disciplinary approach, combining molecular biology, biochemistry, and pharmacology to study the signaling mechanisms of G protein-coupled receptors (GPCRs) and the regulation of adenylyl cyclases. The fact that GPCRs are the target of more the 50% of today’s clinically used drugs emphasizes further the importance of these studies. Much of the work in his lab has focused on members of the dopamine, cannabinoid, serotonin, and adenosine receptor families. Studies have examined the pharmacology of these receptors including the characterization of novel ligands that activate these receptors as well as investigating their ability to modulate the activity of their primary effector, the enzyme adenylyl cyclase (AC). A second area of focus has included examining the effects of persistent Gαi/o-coupled receptor activation in vitro in order to understand and identify molecular changes following chronic drug exposure that may occur in vivo. Much of this work has focused on elucidating the mechanisms and pathways for D2 dopamine receptor-induced heterologous sensitization of adenylyl cyclase. Other exciting studies have used bimolecular fluorescence complementation (BiFC) to “visualize” and localize protein-protein interactions in living cells. BiFC is based on the complementation between fragments of fluorescent proteins that are fused to two interacting proteins. These fluorescent approaches and others are currently being used to study drug-modulated GPCR-AC, AC-AC, and AC-protein interactions in novel cellular models as well as in BiFC screening endeavors. More recent efforts have been focused on the development and execution of screening endeavors relevant to drug discovery and AC signaling. We have developed a number of new HTS assays for human and invertebrate GPCRs as well as individual AC isoforms that include using siRNA and small molecule libraries. We are currently exploring the ability of selective inhibitors of AC isoforms to serve as non-opioid alternatives for chronic pain, agents to treat opioid withdrawal, and for the treatment of alcohol use disorders (AUDs).
研究兴趣
论文共 198 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ASPET 2024 Annual Meeting Abstract - Cellular and Molecular Pharmacology (2024)
Julian Brands, Sergi Bravo, Lars Jürgenliemke,Lukas Grätz,Hannes Schihada, Fabian Frechen,Judith Alenfelder, Cy Pfeil, Paul Georg Ohse,Suzune Hiratsuka,Kouki Kawakami, Luna C Schmacke, Nina Heycke,Asuka Inoue, Gabriele König,Alexander Pfeifer,Dagmar Wachten,Gunnar Schulte, Torsten Steinmetzer,Val J Watts, Jesús Gomeza,Katharina Simon,Evi Kostenis
Nature Communicationsno. 1 (2024): 7684-7684
ASPET 2024 Annual Meeting Abstract - Neuropharmacology (2024)
bioRxiv the preprint server for biology (2023)
IUPHAR/BPS Guide to Pharmacology CITEno. 1 (2023)
Pavel Kraina,Michal Cesnek,Eva Tloustova,Helena Mertlikova-Kaiserova, Camryn J. Fulton, Emily K. Davidson, Brenton P. Smith,Val J. Watts,Zlatko Janeba
Bioorganic & medicinal chemistry (2023): 117508-117508
加载更多
作者统计
#Papers: 198
#Citation: 5595
H-Index: 42
G-Index: 68
Sociability: 6
Diversity: 3
Activity: 34
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn